NovaVision Visual Restoration Therapy (VRT)
Vision loss from stroke/neurological brain damage
CommercialActive
Key Facts
Indication
Vision loss from stroke/neurological brain damage
Phase
Commercial
Status
Active
Company
About Vycor Medical
Vycor Medical is a commercial-stage company with two complementary divisions targeting significant neurological care markets. Its flagship product, the ViewSite Brain Access System (VBAS), is a minimally invasive, FDA-cleared surgical device for brain lesion access, supported by over 50 clinical studies. The NovaVision division commercializes the only FDA-cleared therapy for vision restoration after stroke (VRT) and a complementary compensation therapy (NeuroEyeCoach), addressing a large, underserved patient population. The company boasts a strong intellectual property portfolio with 48 patents and is led by a management team with significant ownership.
View full company profile